TABLE 1.
Baseline characteristics of participants between the BYHW and control groups.
| Characteristic | BYHW (n = 40) | Control (n = 40) | p value |
|---|---|---|---|
| Basic information | |||
| Age (years) | 64.68 ± 7.89 | 64.93 ± 8.13 | 0.889 |
| Male n (%) | 27 (67.50%) | 26 (65.00%) | 0.813 |
| Female n (%) | 13 (32.50%) | 14 (35.00%) | |
| BMI (kg/cm2) | 24.72 ± 3.70 | 24.27 ± 3.60 | 0.584 |
| SBP (mmHg) | 129.40 ± 17.35 | 127.80 ± 17.70 | 0.684 |
| DBP (mmHg) | 80.22 ± 9.94 | 77.50 ± 11.15 | 0.252 |
| Heart rate (bpm) | 69.65 ± 7.75 | 66.72 ± 7.74 | 0.097 |
| Respiratory rate (times/min) | 18.50 ± 1.15 | 18.63 ± 1.24 | 0.628 |
| Medical history n (%) | |||
| History of hypertension | 13 (44.80%) | 20 (48.80%) | 0.112 |
| History of diabetes | 8 (27.60%) | 9 (22.00%) | 0.785 |
| Hyperlipidemia | 5 (17.20%) | 7 (17.10%) | 0.531 |
| Treatment n (%) | |||
| Antiplatelet | 37 (92.50) | 35 (87.50%) | 0.456 |
| Beta-blockers | 19 (47.50%) | 28 (70.00%) | 0.041 |
| ACEI/ARB | 17 (42.5%) | 12 (30.00%) | 0.271 |
| Calcium antagonists | 3 (7.50%) | 7 (17.50%) | 0.176 |
| Statins | 32 (80.00%) | 33 (82.50%) | 0.775 |
| Diuretics | 13 (32.50%) | 10 (25.00%) | 0.459 |
| Aldosterone receptor antagonist | 11 (27.50%) | 12 (30.00%) | 0.812 |
| Nitric acid lipid | 9 (22.50%) | 11 (27.50%) | 0.606 |
| Digoxin | 8 (20.00%) | 4 (10.00%) | 0.21 |
| Clinical index | |||
| TCM syndrome score | 14.65 ± 3.16 | 15.75 ± 4.28 | 0.1948 |
| NYHA classification | |||
| II n (%) | 25 (62.5%) | 25 (62.5%) | 1 |
| III n (%) | 15 (37.5%) | 15 (37.5%) | |
BYHW, Buyang Huanwu decoction; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker; TCM, traditional Chinese medicine; NYHA, New York Heart Association.